CO5221125A1 - Inhibidor de intercambiador de sodio hidrogeno de tipo 1 - Google Patents

Inhibidor de intercambiador de sodio hidrogeno de tipo 1

Info

Publication number
CO5221125A1
CO5221125A1 CO01032977A CO01032977A CO5221125A1 CO 5221125 A1 CO5221125 A1 CO 5221125A1 CO 01032977 A CO01032977 A CO 01032977A CO 01032977 A CO01032977 A CO 01032977A CO 5221125 A1 CO5221125 A1 CO 5221125A1
Authority
CO
Colombia
Prior art keywords
inhibitor
type
hydrogen sodium
nhe
exchanger inhibitor
Prior art date
Application number
CO01032977A
Other languages
English (en)
Spanish (es)
Inventor
George Chen Weichao
Eric David Cox
Perez Angel Guzman
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CO5221125A1 publication Critical patent/CO5221125A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
CO01032977A 2000-04-28 2001-04-27 Inhibidor de intercambiador de sodio hidrogeno de tipo 1 CO5221125A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
CO5221125A1 true CO5221125A1 (es) 2002-11-28

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
CO01032977A CO5221125A1 (es) 2000-04-28 2001-04-27 Inhibidor de intercambiador de sodio hidrogeno de tipo 1

Country Status (40)

Country Link
EP (1) EP1276737A1 (xx)
JP (1) JP2003531900A (xx)
KR (1) KR20020093079A (xx)
CN (1) CN1225466C (xx)
AP (1) AP2002002651A0 (xx)
AR (1) AR028375A1 (xx)
AU (1) AU2001235896A1 (xx)
BG (1) BG107139A (xx)
BR (1) BR0110268A (xx)
CA (1) CA2407535A1 (xx)
CO (1) CO5221125A1 (xx)
CR (1) CR6797A (xx)
CZ (1) CZ20023408A3 (xx)
DZ (1) DZ3310A1 (xx)
EA (1) EA004882B1 (xx)
EE (1) EE200200615A (xx)
GT (1) GT200100064A (xx)
HN (1) HN2001000042A (xx)
HR (1) HRP20020851A2 (xx)
HU (1) HUP0300651A2 (xx)
IL (1) IL152075A0 (xx)
IS (2) IS6567A (xx)
MA (1) MA26897A1 (xx)
MX (1) MXPA02010600A (xx)
MY (1) MY133842A (xx)
NO (1) NO20025132L (xx)
NZ (1) NZ521348A (xx)
OA (1) OA12256A (xx)
PA (1) PA8513301A1 (xx)
PE (1) PE20011270A1 (xx)
PL (1) PL357765A1 (xx)
SK (1) SK14872002A3 (xx)
SV (1) SV2002000418A (xx)
TN (1) TNSN01065A1 (xx)
TR (1) TR200202439T2 (xx)
UA (1) UA73348C2 (xx)
UY (1) UY26680A1 (xx)
WO (1) WO2001083470A1 (xx)
YU (1) YU79602A (xx)
ZA (1) ZA200208605B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004518686A (ja) * 2001-01-31 2004-06-24 ファイザー・プロダクツ・インク ナトリウム−水素交換輸送体1型阻害剤のエタノラート
MXPA04004685A (es) * 2001-12-19 2004-08-12 Pfizer Prod Inc Procedimientos para preparar inhibidores de tipo-1 de intercambiador sodio-hidrogeno.
WO2003092694A1 (en) * 2002-05-02 2003-11-13 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
AU2004212957A1 (en) * 2003-02-14 2004-09-02 Smithkline Beecham Corporation Novel compounds
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100449600B1 (ko) * 1998-02-27 2004-09-21 화이자 프로덕츠 인크. 허혈 치료용 n-[(치환된 5원 디아자 이불포화 고리)카르보닐] 구아니딘 유도체

Also Published As

Publication number Publication date
PE20011270A1 (es) 2001-12-12
AU2001235896A1 (en) 2001-11-12
IS6567A (is) 2002-09-24
EA200201023A1 (ru) 2003-02-27
UY26680A1 (es) 2001-12-28
NO20025132L (no) 2002-12-12
IL152075A0 (en) 2003-05-29
PA8513301A1 (es) 2003-09-05
EE200200615A (et) 2004-04-15
BG107139A (bg) 2003-07-31
MY133842A (en) 2007-11-30
EA004882B1 (ru) 2004-08-26
HUP0300651A2 (hu) 2003-07-28
PL357765A1 (en) 2004-07-26
JP2003531900A (ja) 2003-10-28
CN1225466C (zh) 2005-11-02
HN2001000042A (es) 2001-07-09
NO20025132D0 (no) 2002-10-25
ZA200208605B (en) 2003-10-24
CR6797A (es) 2004-05-17
WO2001083470A1 (en) 2001-11-08
CZ20023408A3 (cs) 2004-01-14
NZ521348A (en) 2004-09-24
IS6588A (is) 2002-10-21
SK14872002A3 (sk) 2004-03-02
AR028375A1 (es) 2003-05-07
OA12256A (en) 2003-11-06
CA2407535A1 (en) 2001-11-08
EP1276737A1 (en) 2003-01-22
CN1426404A (zh) 2003-06-25
AP2002002651A0 (en) 2002-12-31
UA73348C2 (en) 2005-07-15
MA26897A1 (fr) 2004-12-20
YU79602A (xx) 2006-05-25
DZ3310A1 (fr) 2001-11-07
SV2002000418A (es) 2002-07-03
KR20020093079A (ko) 2002-12-12
TNSN01065A1 (fr) 2005-11-10
TR200202439T2 (tr) 2003-02-21
HRP20020851A2 (en) 2005-02-28
GT200100064A (es) 2002-03-22
MXPA02010600A (es) 2003-03-10
BR0110268A (pt) 2003-12-30

Similar Documents

Publication Publication Date Title
CO5160257A1 (es) La n-piperidino-5-(4-bromofenil)-1-(2,4-diclorofenil)-4-etilpirazol-3-carboxamida, sus sales, su preparacion y las composiciones farmaceuticas que la contienen
CO5210864A1 (es) Nuevos derivados de bencimidazolonas que tienen afinidad para receptores mezclados de serotonina y dopamina
CO5271657A1 (es) Derivados de azaindol
CO5310550A1 (es) Nuevo derivado de androstano antiinflamatorio, su polimorfo, sus formas cristalinas solvatadas, composiciones farmaceutias, proceso para prepararlo, intermediario
GT199900022A (es) Compuestos para el tratamiento de la isquemia
BR0311132A (pt) Inibidores do vìrus da hepatite c
CO5130008A1 (es) Composicion oral compactada famaceuticamente efectiva a base de entacapona, nitecapona y croscarmelasa de sodio y metodo para preparar dicha composicion
BR0109542A (pt) Derivados de imidazopirina alquilados
RS50229B (sr) Analozi vitamina d3
CO5070675A1 (es) Pirroles sustituidos
CO5221125A1 (es) Inhibidor de intercambiador de sodio hidrogeno de tipo 1
CO5150178A1 (es) Bromohidrato de eletriptan monohidrato y procedimiento para su preparacion
CO5150165A1 (es) Inhibidores de proteasa: tipo catepsina k
CO5080759A1 (es) Biarilacetilenos como inhibidores de la metaloproteasa de matriz
GT199900113A (es) Inhibidores de las fkbp.
CO5231155A1 (es) Benzoilciclohexanodionas substituidas
BR0115616A (pt) Preparação de inibidores de permutadores sódio-hidrogênio do tipo 1
CO5080758A1 (es) DERIVADOS DE 3-(2-oxo-[1,3´]BIPIRROLODINIL-3-ILIDENMETIL
CO5261576A1 (es) Compuestos
CO5160328A1 (es) Derivados de etan sulfonil-piperidina
CO5271714A1 (es) Cristales de inhibidor del intercambiador de sodio-hidrogeno
BR0107204A (pt) Inibidores da angiogênese de hidrazida e alcoxiamida
CO5251436A1 (es) Uso de azoles para la prevencion del cancer de piel
CO5190678A1 (es) Terapia combinada para el tratamiento de la migrana
AR006675A1 (es) 4-benzoilisotiazoles herbicidas, procedimiento para obtenerlas, las composiciones herbicidas que las contienen y el procedimiento de aplicacionde dichos compuestos.

Legal Events

Date Code Title Description
FC Application refused